Pioneering a new era for brain diseases
Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company pioneering precision medicines for brain diseases. Founded in 2019, Neumora integrates neuroscience and data science across a 7-program pipeline targeting conditions including Alzheimer's agitation, schizophrenia, and depression, with the goal of improving outcomes for the 1.5 billion people living with brain diseases.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2022
Oct 2021
Create a free account to see which investors have funded this company.
Create Free Account
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
